Microtrast

Barium sulfate, the active ingredient in Microtrast, is a contrast agent presented as an oral suspension for gastrointestinal imaging use. It provides radiopaque contrast that enhances X‑ray and CT visualization of the GI tract during procedures such as barium swallow and barium enema.

GNH USA supplies Microtrast as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets. The product meets European Union pharmacopeial standards and is manufactured under GMP conditions.

Microtrast, a barium sulfate oral contrast agent, is used for radiographic evaluation of the gastrointestinal tract. - Barium swallow: Improves visualization of the esophagus and upper GI tract during fluoroscopic examination. - Barium enema: Enhances contrast of the colon and rectum for diagnostic imaging of lower GI disorders. - CT enterography: Provides radiopaque contrast for computed tomography assessment of small bowel pathology.

Oral barium sulfate may cause gastrointestinal and systemic reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild discomfort after ingestion. - Abdominal cramping: transient pain during bowel distension. - Constipation: temporary difficulty passing stool. - Metallic taste: brief aftertaste in the mouth.

Serious or Rare Side Effects: - Barium impaction: obstruction of the bowel requiring medical attention. - Aspiration pneumonia: inhalation of barium into the lungs. - Allergic reaction: rash, itching, or swelling.

Before administering Microtrast, clinicians should consider several safety measures. - Patient assessment: verify no known hypersensitivity to barium sulfate. - Gastrointestinal obstruction: avoid use in patients with suspected or confirmed bowel obstruction. - Recent surgery: postpone administration if recent GI surgery may increase perforation risk. - Pregnancy: use only if clearly needed, as safety data are limited. - Contrast preparation: ensure proper mixing of suspension before administration. - Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture.

Barium sulfate can interact with certain oral agents, affecting image quality or patient safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: may reduce barium suspension homogeneity. - Iron supplements: can cause precipitation and reduce image quality. - Calcium‑containing laxatives: may interfere with barium coating.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may alter gastric pH affecting barium distribution. - Diuretics: increased fluid loss may affect patient tolerance. - Antiemetics: may mask nausea symptoms.